SPAC323.04 Antibody

What is SPAC323.04 and what cellular functions does it serve?

SPAC323.04 functions as a mitochondrial ATPase that is critical for maintaining mitochondrial function and cellular redox homeostasis. Based on genome-wide screening studies, SPAC323.04 has been identified as part of a group of genes whose deletion results in hypersensitivity to FTY720 (fingolimod), a compound known to induce reactive oxygen species (ROS) production . The protein appears to be essential for regulating mitochondrial ROS levels under both basal and stress conditions. Deletion mutants lacking SPAC323.04 display significantly elevated steady-state ROS levels (≥150% compared to wild-type cells), indicating its crucial role in maintaining oxidative balance .

How does SPAC323.04 compare to other mitochondrial proteins involved in ROS regulation?

SPAC323.04 belongs to a functional group similar to other mitochondrial proteins like Coq3 and Atp15, which are involved in maintaining ROS homeostasis. Research has shown that mutants defective in these proteins share a common phenotype characterized by increased basal ROS levels and hypersensitivity to oxidative stress-inducing agents . Unlike some other mitochondrial proteins, SPAC323.04 mutants show particularly heightened sensitivity to FTY720, suggesting its potentially unique role in responding to this specific stressor. When examining mitochondrial function, researchers should consider that SPAC323.04, Coq3, and Atp15 mutants are more prone to produce ROS than wild-type strains, making them important targets for antibody-based detection in mitochondrial dysfunction studies .

What are the most suitable experimental models for studying SPAC323.04?

Based on current research methodologies, Schizosaccharomyces pombe (fission yeast) serves as an excellent model for studying SPAC323.04 function. Several experimental approaches have proven effective:

• Deletion mutant studies: Using ΔSPAC323.04 strains from deletion libraries (similar to the BIONEER collection mentioned in the literature) allows for phenotypic analysis and stress response characterization .

• Complementation assays: Reintroducing SPAC323.04 into deletion mutants to confirm phenotype rescue.

• ROS measurement assays: Utilizing fluorescent probes to quantify ROS levels in wild-type versus mutant strains under various treatment conditions.

• Microscopy: Subcellular localization studies using antibodies or fluorescently-tagged SPAC323.04 to confirm mitochondrial localization.

When designing experiments, researchers should consider using YES (yeast extract plus supplements) as growth medium, as it was successfully used in previous SPAC323.04 functional studies .

What are the specific challenges in generating effective antibodies against SPAC323.04?

Developing specific antibodies against SPAC323.04 presents several technical challenges:

• Mitochondrial localization: As a mitochondrial protein, SPAC323.04 may have limited exposure of immunogenic epitopes.

• Evolutionary conservation: If regions of SPAC323.04 are highly conserved, generating species-specific antibodies may be difficult.

• Post-translational modifications: Potential modifications might affect antibody recognition of the native protein.

• Specificity validation: Thorough validation is essential, particularly using knockout/deletion strains as negative controls.

Researchers should consider using multiple immunization strategies, combining both peptide antigens from unique regions of SPAC323.04 and recombinant protein fragments. Validation should follow similar rigor to that demonstrated for other specialized antibodies, such as the oligodendrocyte marker O4 antibody, which underwent extensive specificity testing against relevant cell types .

How can researchers validate the specificity of SPAC323.04 antibodies?

A robust validation strategy for SPAC323.04 antibodies should include:

• Western blot analysis comparing wild-type and ΔSPAC323.04 mutant strains to confirm absence of signal in the knockout.

• Immunoprecipitation followed by mass spectrometry to confirm target identity.

• Immunofluorescence microscopy comparing staining patterns in wild-type versus mutant cells.

• Competitive blocking assays using recombinant SPAC323.04 protein.

• Cross-reactivity testing against related mitochondrial ATPases.

Flow cytometry can also be employed as a validation method, similar to approaches used for other specialized antibodies such as oligodendrocyte marker O4 antibody, where differentiated cells were tested against isotype control antibodies to confirm specificity .

What expression systems are optimal for producing recombinant SPAC323.04 for antibody production?

For generating recombinant SPAC323.04 protein as an immunogen:

• Bacterial expression systems: E. coli BL21(DE3) with appropriate solubility tags (such as MBP or SUMO) can help overcome solubility issues common with mitochondrial proteins.

• Yeast expression systems: S. cerevisiae or P. pastoris may provide more native-like post-translational modifications.

• Insect cell expression: Baculovirus systems might be superior for maintaining proper folding of complex proteins.

When designing expression constructs, researchers should carefully consider:

• Including only the mature protein sequence (excluding mitochondrial targeting sequences)

• Optimizing codon usage for the expression host

• Adding purification tags that can be removed without affecting protein structure

• Expressing distinct domains separately if the full-length protein proves challenging

How can SPAC323.04 antibodies be optimized for immunofluorescence microscopy applications?

For optimal immunofluorescence results when studying SPAC323.04:

• Fixation method: Test both paraformaldehyde (2-4%) and methanol fixation, as mitochondrial proteins may respond differently to various fixatives.

• Permeabilization: Use Triton X-100 (0.1-0.5%) or digitonin (10-50 μg/ml) for selective mitochondrial membrane permeabilization.

• Blocking: Employ 5% BSA or normal serum from the secondary antibody host species.

• Antibody dilution: Begin with 1:100-1:500 dilutions and optimize based on signal-to-noise ratio.

• Co-staining: Include established mitochondrial markers (e.g., MitoTracker or antibodies against known mitochondrial proteins) to confirm localization.

For validation, researchers should include appropriate controls similar to those used for specialized antibodies like the oligodendrocyte marker O4, where isotype control antibodies are used to establish staining specificity .

What are effective protocols for detecting SPAC323.04 expression in stress response studies?

When using SPAC323.04 antibodies to study stress responses, particularly in FTY720 or oxidative stress experiments:

• Sample preparation:

  • Expose cells to graduated concentrations of stressors (10-30 μM FTY720 or 2 mM H₂O₂ as reference points)

  • Harvest cells at multiple time points (0, 1, 3, 6 hours) to capture dynamic responses

  • Include both whole cell lysates and isolated mitochondrial fractions

• Detection methods:

  • Western blotting: Use 10-12% SDS-PAGE gels with PVDF membranes for optimal transfer of mitochondrial proteins

  • Quantitative immunofluorescence: Measure signal intensity changes in response to treatments

  • Flow cytometry: For population-level analysis of protein expression changes

• Controls:

  • Include untreated samples as baseline controls

  • Compare wild-type and ΔSPAC323.04 strains to validate antibody specificity

  • Include known stress-responsive mitochondrial proteins as positive controls

This approach parallels established methods used to study stress responses in yeast strains, where careful concentration optimization of stressors like FTY720 (10-30 μM) has proven effective in revealing phenotypic differences .

How can SPAC323.04 antibodies be used in conjunction with ROS detection methods?

For comprehensive analysis of SPAC323.04's role in ROS homeostasis:

• Simultaneous analysis protocol:

  • Perform dual staining with SPAC323.04 antibodies and ROS-sensitive dyes (e.g., DCFDA, MitoSOX)

  • Quantify correlations between SPAC323.04 expression levels and ROS production at the single-cell level

  • Compare results between wild-type cells and cells with altered SPAC323.04 expression

• Time-course experiments:

  • Monitor ROS levels and SPAC323.04 expression at multiple time points after stress induction

  • This approach can reveal whether changes in SPAC323.04 precede or follow ROS elevation

• Pharmacological interventions:

  • Use mitochondrial-targeted antioxidants to determine if SPAC323.04 expression changes in response to ROS neutralization

  • Apply mitochondrial ATPase inhibitors to assess their impact on SPAC323.04 levels and ROS production

This integrated approach builds on established methodologies that have successfully demonstrated elevated ROS levels (≥150% compared to wild-type) in SPAC323.04 mutants after treatments with stressors like FTY720 or H₂O₂ .

How can SPAC323.04 antibodies contribute to understanding mitochondrial dysfunction in disease models?

SPAC323.04 antibodies can provide valuable insights into mitochondrial dysfunction across various disease models:

• Neurodegenerative disease models:

  • Analyze SPAC323.04 expression in cellular or animal models of Parkinson's, Alzheimer's, or ALS

  • Investigate correlations between SPAC323.04 levels and mitochondrial morphology changes

• Cancer metabolism studies:

  • Compare SPAC323.04 expression between normal and cancer cells with altered mitochondrial function

  • Assess whether SPAC323.04 levels change in response to metabolic reprogramming

• Aging research:

  • Examine age-related changes in SPAC323.04 expression and their relationship to mitochondrial ROS accumulation

  • Test interventions that extend lifespan for their effects on SPAC323.04 levels

These applications build on findings that SPAC323.04 mutants show increased ROS production under both basal and stressed conditions, suggesting its potential role in various pathological states characterized by mitochondrial dysfunction and oxidative stress .

What methodological approaches can be used to study interactions between SPAC323.04 and other mitochondrial proteins?

To investigate SPAC323.04's protein interaction network:

• Co-immunoprecipitation approaches:

  • Use SPAC323.04 antibodies coupled to magnetic or agarose beads

  • Perform pull-downs from mitochondrial fractions under varying conditions (normal, oxidative stress)

  • Identify binding partners through mass spectrometry

  • Confirm key interactions with reverse co-IP using antibodies against identified partners

• Proximity labeling techniques:

  • Generate SPAC323.04 fusion proteins with BioID or APEX2

  • Identify proteins in close proximity to SPAC323.04 in living cells

  • Compare interactome under normal versus stressed conditions

• Fluorescence-based interaction assays:

  • Implement FRET or BiFC approaches with fluorescently-tagged SPAC323.04

  • Monitor dynamic interactions in response to mitochondrial stressors

These methods can help elucidate whether SPAC323.04 functions in a complex with other proteins identified in FTY720 sensitivity screens, such as Coq3 and Atp15, which share similar phenotypes regarding ROS production .

How can researchers use SPAC323.04 antibodies to investigate the protein's role in FTY720-mediated cellular responses?

For studying SPAC323.04's specific involvement in FTY720 responses:

• Dose-response experiments:

  • Treat cells with varying concentrations of FTY720 (10-30 μM range)

  • Monitor SPAC323.04 expression, localization, and post-translational modifications

  • Compare responses between wild-type and genetically modified strains

• Time-course analysis:

  • Assess acute versus chronic effects of FTY720 on SPAC323.04

  • Compare temporal relationships between changes in SPAC323.04, ROS levels, and cellular viability

• Structure-function studies:

  • Use domain-specific antibodies to determine which regions of SPAC323.04 are affected by FTY720

  • Investigate whether FTY720 directly interacts with SPAC323.04 or affects it indirectly

• Pathway analysis:

  • Combine SPAC323.04 antibody-based detection with inhibitors of specific signaling pathways

  • Determine whether SPAC323.04's response to FTY720 depends on particular cellular pathways

This approach builds directly on research that identified SPAC323.04 as part of a group of genes whose deletion confers hypersensitivity to FTY720, with experiments showing that 10-20 μM FTY720 is optimal for detecting these phenotypic differences .

How can researchers address weak or inconsistent signals when using SPAC323.04 antibodies?

When facing detection challenges with SPAC323.04 antibodies:

• Sample preparation optimization:

  • For mitochondrial proteins like SPAC323.04, standard lysis methods may be insufficient

  • Test specialized mitochondrial extraction buffers containing higher detergent concentrations

  • Include protease inhibitor cocktails specific for mitochondrial proteases

  • Consider using mechanical disruption methods (e.g., glass beads for yeast cells)

• Signal enhancement strategies:

  • Implement epitope retrieval techniques for fixed samples

  • Use signal amplification systems (e.g., tyramide signal amplification)

  • Optimize blocking conditions to reduce background while preserving specific signals

  • Consider concentrated antibody incubation at 4°C overnight rather than short incubations

• Validation using overexpression systems:

  • Generate cells overexpressing tagged SPAC323.04 as positive controls

  • Use these to establish optimal detection parameters before examining endogenous expression

These approaches are particularly important given that mitochondrial proteins can be challenging to detect due to their localization and sometimes lower abundance compared to cytosolic proteins.

What strategies can address potential cross-reactivity with other mitochondrial ATPases?

To ensure antibody specificity when studying SPAC323.04:

• Comprehensive specificity testing:

  • Perform Western blots on samples from wild-type strains and strains with deletions of SPAC323.04 and related ATPases

  • Include recombinant proteins of SPAC323.04 and similar ATPases as controls

  • Use competitive binding assays with purified proteins to assess cross-reactivity

• Epitope-focused approach:

  • Generate antibodies against unique regions of SPAC323.04 that differ from other ATPases

  • Use peptide competition assays to confirm epitope specificity

  • Consider using multiple antibodies targeting different regions of SPAC323.04

• Genetic verification:

  • Always validate key findings using genetic approaches (gene deletion, siRNA, CRISPR)

  • Compare antibody staining patterns with fluorescently tagged SPAC323.04 expression

This methodical approach to validation parallels techniques used for other specialized antibodies where specificity is critical for experimental interpretation .

How can researchers optimize SPAC323.04 antibody performance in different experimental systems?

For adapting SPAC323.04 antibodies across diverse experimental platforms:

• Western blotting optimization:

  • Test multiple blocking agents (BSA, milk, commercial blockers)

  • Optimize primary antibody concentration and incubation conditions

  • Evaluate different detection systems (HRP, fluorescent secondaries)

  • Consider using gradient gels to better resolve SPAC323.04 from similar-sized proteins

• Immunofluorescence refinement:

  • Test multiple fixation protocols (paraformaldehyde, methanol, acetone)

  • Optimize permeabilization conditions for mitochondrial access

  • Use confocal microscopy with appropriate controls to confirm mitochondrial localization

  • Implement super-resolution techniques for detailed subcellular localization

• Flow cytometry adaptation:

  • Develop specific cell permeabilization protocols for intracellular/mitochondrial staining

  • Use fluorochrome-conjugated primary antibodies for increased sensitivity

  • Include isotype controls and single-color controls for proper compensation

  • Apply similar principles to those used for established flow cytometry antibodies like oligodendrocyte marker O4

By systematically optimizing these parameters, researchers can ensure robust and reproducible results across different experimental platforms when using SPAC323.04 antibodies.